Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Пути совершенствования антимикробной терапии уретритов у мужчин
Пути совершенствования антимикробной терапии уретритов у мужчин
Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Полный текст
Список литературы
1. Update to CDC's sexually transmitted diseases treatment guidelines, 2006: fluoroquinolones no longer recommended for treatment of gonococcal infections. MMWR Morb Mortal Wkly Rep 2007; 56 (14): 332–6.
2. Availability of cefixime 400 mg tablets--United States, April 2008. MMWR Morb Mortal Wkly Rep 2008; 57 (16): 435.
3. Fine D, Dicker L, Mosure D, Berman S. Increasing chlamydia positivity in women screened in family planning clinics: do we know why? Sex Transm Dis Jan 2008; 35 (1): 47–52.
4. Greene JP, Stafford E. Prevalence of Chlamydia trachomatis among active duty male soldiers reporting to a troop medical clinic for routine health care. South Med J May 2007; 100 (5): 478–81.
5. Franceschi S, Smith JS, van den Brule A et al. Cervical infection with Chlamydia trachomatis and Neisseria gonorrhoeae in women from ten areas in four continents. A cross-sectional study. Sex Transm Dis 2007; 34 (8): 563–9.
6. Yu MC, Li LH, Tang LH, Chen KT. Genital chlamydial infection among male attendees at a sexually transmitted disease clinic in urban Taiwan. Public Health 2007; 121 (7): 534–9.
7. Somani J, Bhullar VB, Workowski KA et al. Multiple drug-resistant Chlamydia trachomatis associated with clinical treatment failure. J Infect Dis 2000; 181 (4): 1421–7.
8. Workowski KA, Berman SM. Sexually transmitted diseases treatment guidelines, 2006. MMWR Recomm Rep 2006; 55 (RR-11): 1–94.
9. Radcliffe KW. Introduction. European STD guidelines. Int J STD AIDS 2001; 12 (Suppl. 3): 2–3.
10. WHO. Guidelines for the management of sexually transmitted infections. Geneva: World Health Organization; 2003.
11. Association for Genitourinary Medicine (AGUM) MSftSoVDM. 2002 national guideline on the management of non-gonococcal urethritis.: London: Association for Genitourinary Medicine (AGUM), Medical Society for the Study of Venereal Disease (MSSVD). 2002.
12. Lau CY, Qureshi AK. Azithromycin versus doxycycline for genital chlamydial infections: a meta-analysis of randomized clinical trials. Sex Transm Dis 2002; 29 (9): 497–502.
13. Geisler WM. Management of uncomplicated Chlamydia trachomatis infections in adolescents and adults: evidence reviewed for the 2006 Centers for Disease Control and Prevention sexually transmitted diseases treatment guidelines. Clin Infect Dis 2007; 44 (Suppl. 3): S77–83.
14. Higgins J, Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.0 [updated February 2008]. The Cochrane Collaboration, 2008. Chichester, UK: John Wiley & Sons, Ltd.; 2006.
15. Steingrimsson O, Olafsson JH, Thorarinsson H et al. Azithromycin in the treatment of sexually transmitted disease. J Antimicrob Chemother 1990; 25 (Suppl. A): 109–14.
16. Whatley JD, Thin RN, Mumtaz G, Ridgway GL. Azithromycin vs doxycycline in the treatment of non-gonococcal urethritis. Int J STD AIDS 1991; 2 (4): 248–51.
17. Martin DH, Mroczkowski TF, Dalu ZA et al. A controlled trial of a single dose of azithromycin for the treatment of chlamydial urethritis and cervicitis. The Azithromycin for Chlamydial Infections Study Group. N Engl J Med 1992; 327 (13): 921–5.
18. Nilsen A, Halsos A, Johansen A et al. A double blind study of single dose azithromycin and doxycycline in the treatment of chlamydial urethritis in males. Genitourin Med 1992; 68 (5): 325–7.
19. Lister PJ, Balechandran T, Ridgway GL, Robinson AJ. Comparison of azithromycin and doxycycline in the treatment of non-gonococcal urethritis in men. (Suppl. E) 1993; 31.
20. Lauharanta J, Saarinen K, Mustonen MT, Happonen HP. Single-dose oral azithromycin versus seven-day doxycycline in the treatment of non-gonococcal urethritis in males. J Antimicrob Chemother 1993; 31 (Suppl. E): 177–83.
21. Steingrimsson O, Olafsson JH, Thorarinsson H et al. Single dose azithromycin treatment of gonorrhea and infections caused by C. trachomatis and U. urealyticum in men. Sex Transm Dis 1994; 21 (1): 43–6.
22. Stamm WE, Hicks CB, Martin DH et al. Azithromycin for empirical treatment of the nongonococcal urethritis syndrome in men. A randomized double-blind study. Jama 1995; 274 (7): 545–9.
23. Jaspersen D. Drug Safety 2000; 22 (3): 237–49.
24. Bradshaw CS, Jensen JS, Tabrizi SN et al. Azithromycin failure in Mycoplasma genitalium urethritis. Emerg Infect Dis 2006; 12 (7): 1149–52.
25. Ross JD, Jensen JS. Mycoplasma genitalium as a sexually transmitted infection: implications for screening, testing, and treatment. Sex Transm Infect 2006; 82 (4): 269–71.
2. Availability of cefixime 400 mg tablets--United States, April 2008. MMWR Morb Mortal Wkly Rep 2008; 57 (16): 435.
3. Fine D, Dicker L, Mosure D, Berman S. Increasing chlamydia positivity in women screened in family planning clinics: do we know why? Sex Transm Dis Jan 2008; 35 (1): 47–52.
4. Greene JP, Stafford E. Prevalence of Chlamydia trachomatis among active duty male soldiers reporting to a troop medical clinic for routine health care. South Med J May 2007; 100 (5): 478–81.
5. Franceschi S, Smith JS, van den Brule A et al. Cervical infection with Chlamydia trachomatis and Neisseria gonorrhoeae in women from ten areas in four continents. A cross-sectional study. Sex Transm Dis 2007; 34 (8): 563–9.
6. Yu MC, Li LH, Tang LH, Chen KT. Genital chlamydial infection among male attendees at a sexually transmitted disease clinic in urban Taiwan. Public Health 2007; 121 (7): 534–9.
7. Somani J, Bhullar VB, Workowski KA et al. Multiple drug-resistant Chlamydia trachomatis associated with clinical treatment failure. J Infect Dis 2000; 181 (4): 1421–7.
8. Workowski KA, Berman SM. Sexually transmitted diseases treatment guidelines, 2006. MMWR Recomm Rep 2006; 55 (RR-11): 1–94.
9. Radcliffe KW. Introduction. European STD guidelines. Int J STD AIDS 2001; 12 (Suppl. 3): 2–3.
10. WHO. Guidelines for the management of sexually transmitted infections. Geneva: World Health Organization; 2003.
11. Association for Genitourinary Medicine (AGUM) MSftSoVDM. 2002 national guideline on the management of non-gonococcal urethritis.: London: Association for Genitourinary Medicine (AGUM), Medical Society for the Study of Venereal Disease (MSSVD). 2002.
12. Lau CY, Qureshi AK. Azithromycin versus doxycycline for genital chlamydial infections: a meta-analysis of randomized clinical trials. Sex Transm Dis 2002; 29 (9): 497–502.
13. Geisler WM. Management of uncomplicated Chlamydia trachomatis infections in adolescents and adults: evidence reviewed for the 2006 Centers for Disease Control and Prevention sexually transmitted diseases treatment guidelines. Clin Infect Dis 2007; 44 (Suppl. 3): S77–83.
14. Higgins J, Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.0 [updated February 2008]. The Cochrane Collaboration, 2008. Chichester, UK: John Wiley & Sons, Ltd.; 2006.
15. Steingrimsson O, Olafsson JH, Thorarinsson H et al. Azithromycin in the treatment of sexually transmitted disease. J Antimicrob Chemother 1990; 25 (Suppl. A): 109–14.
16. Whatley JD, Thin RN, Mumtaz G, Ridgway GL. Azithromycin vs doxycycline in the treatment of non-gonococcal urethritis. Int J STD AIDS 1991; 2 (4): 248–51.
17. Martin DH, Mroczkowski TF, Dalu ZA et al. A controlled trial of a single dose of azithromycin for the treatment of chlamydial urethritis and cervicitis. The Azithromycin for Chlamydial Infections Study Group. N Engl J Med 1992; 327 (13): 921–5.
18. Nilsen A, Halsos A, Johansen A et al. A double blind study of single dose azithromycin and doxycycline in the treatment of chlamydial urethritis in males. Genitourin Med 1992; 68 (5): 325–7.
19. Lister PJ, Balechandran T, Ridgway GL, Robinson AJ. Comparison of azithromycin and doxycycline in the treatment of non-gonococcal urethritis in men. (Suppl. E) 1993; 31.
20. Lauharanta J, Saarinen K, Mustonen MT, Happonen HP. Single-dose oral azithromycin versus seven-day doxycycline in the treatment of non-gonococcal urethritis in males. J Antimicrob Chemother 1993; 31 (Suppl. E): 177–83.
21. Steingrimsson O, Olafsson JH, Thorarinsson H et al. Single dose azithromycin treatment of gonorrhea and infections caused by C. trachomatis and U. urealyticum in men. Sex Transm Dis 1994; 21 (1): 43–6.
22. Stamm WE, Hicks CB, Martin DH et al. Azithromycin for empirical treatment of the nongonococcal urethritis syndrome in men. A randomized double-blind study. Jama 1995; 274 (7): 545–9.
23. Jaspersen D. Drug Safety 2000; 22 (3): 237–49.
24. Bradshaw CS, Jensen JS, Tabrizi SN et al. Azithromycin failure in Mycoplasma genitalium urethritis. Emerg Infect Dis 2006; 12 (7): 1149–52.
25. Ross JD, Jensen JS. Mycoplasma genitalium as a sexually transmitted infection: implications for screening, testing, and treatment. Sex Transm Infect 2006; 82 (4): 269–71.
2. Availability of cefixime 400 mg tablets--United States, April 2008. MMWR Morb Mortal Wkly Rep 2008; 57 (16): 435.
3. Fine D, Dicker L, Mosure D, Berman S. Increasing chlamydia positivity in women screened in family planning clinics: do we know why? Sex Transm Dis Jan 2008; 35 (1): 47–52.
4. Greene JP, Stafford E. Prevalence of Chlamydia trachomatis among active duty male soldiers reporting to a troop medical clinic for routine health care. South Med J May 2007; 100 (5): 478–81.
5. Franceschi S, Smith JS, van den Brule A et al. Cervical infection with Chlamydia trachomatis and Neisseria gonorrhoeae in women from ten areas in four continents. A cross-sectional study. Sex Transm Dis 2007; 34 (8): 563–9.
6. Yu MC, Li LH, Tang LH, Chen KT. Genital chlamydial infection among male attendees at a sexually transmitted disease clinic in urban Taiwan. Public Health 2007; 121 (7): 534–9.
7. Somani J, Bhullar VB, Workowski KA et al. Multiple drug-resistant Chlamydia trachomatis associated with clinical treatment failure. J Infect Dis 2000; 181 (4): 1421–7.
8. Workowski KA, Berman SM. Sexually transmitted diseases treatment guidelines, 2006. MMWR Recomm Rep 2006; 55 (RR-11): 1–94.
9. Radcliffe KW. Introduction. European STD guidelines. Int J STD AIDS 2001; 12 (Suppl. 3): 2–3.
10. WHO. Guidelines for the management of sexually transmitted infections. Geneva: World Health Organization; 2003.
11. Association for Genitourinary Medicine (AGUM) MSftSoVDM. 2002 national guideline on the management of non-gonococcal urethritis.: London: Association for Genitourinary Medicine (AGUM), Medical Society for the Study of Venereal Disease (MSSVD). 2002.
12. Lau CY, Qureshi AK. Azithromycin versus doxycycline for genital chlamydial infections: a meta-analysis of randomized clinical trials. Sex Transm Dis 2002; 29 (9): 497–502.
13. Geisler WM. Management of uncomplicated Chlamydia trachomatis infections in adolescents and adults: evidence reviewed for the 2006 Centers for Disease Control and Prevention sexually transmitted diseases treatment guidelines. Clin Infect Dis 2007; 44 (Suppl. 3): S77–83.
14. Higgins J, Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.0 [updated February 2008]. The Cochrane Collaboration, 2008. Chichester, UK: John Wiley & Sons, Ltd.; 2006.
15. Steingrimsson O, Olafsson JH, Thorarinsson H et al. Azithromycin in the treatment of sexually transmitted disease. J Antimicrob Chemother 1990; 25 (Suppl. A): 109–14.
16. Whatley JD, Thin RN, Mumtaz G, Ridgway GL. Azithromycin vs doxycycline in the treatment of non-gonococcal urethritis. Int J STD AIDS 1991; 2 (4): 248–51.
17. Martin DH, Mroczkowski TF, Dalu ZA et al. A controlled trial of a single dose of azithromycin for the treatment of chlamydial urethritis and cervicitis. The Azithromycin for Chlamydial Infections Study Group. N Engl J Med 1992; 327 (13): 921–5.
18. Nilsen A, Halsos A, Johansen A et al. A double blind study of single dose azithromycin and doxycycline in the treatment of chlamydial urethritis in males. Genitourin Med 1992; 68 (5): 325–7.
19. Lister PJ, Balechandran T, Ridgway GL, Robinson AJ. Comparison of azithromycin and doxycycline in the treatment of non-gonococcal urethritis in men. (Suppl. E) 1993; 31.
20. Lauharanta J, Saarinen K, Mustonen MT, Happonen HP. Single-dose oral azithromycin versus seven-day doxycycline in the treatment of non-gonococcal urethritis in males. J Antimicrob Chemother 1993; 31 (Suppl. E): 177–83.
21. Steingrimsson O, Olafsson JH, Thorarinsson H et al. Single dose azithromycin treatment of gonorrhea and infections caused by C. trachomatis and U. urealyticum in men. Sex Transm Dis 1994; 21 (1): 43–6.
22. Stamm WE, Hicks CB, Martin DH et al. Azithromycin for empirical treatment of the nongonococcal urethritis syndrome in men. A randomized double-blind study. Jama 1995; 274 (7): 545–9.
23. Jaspersen D. Drug Safety 2000; 22 (3): 237–49.
24. Bradshaw CS, Jensen JS, Tabrizi SN et al. Azithromycin failure in Mycoplasma genitalium urethritis. Emerg Infect Dis 2006; 12 (7): 1149–52.
25. Ross JD, Jensen JS. Mycoplasma genitalium as a sexually transmitted infection: implications for screening, testing, and treatment. Sex Transm Infect 2006; 82 (4): 269–71.
________________________________________________
2. Availability of cefixime 400 mg tablets--United States, April 2008. MMWR Morb Mortal Wkly Rep 2008; 57 (16): 435.
3. Fine D, Dicker L, Mosure D, Berman S. Increasing chlamydia positivity in women screened in family planning clinics: do we know why? Sex Transm Dis Jan 2008; 35 (1): 47–52.
4. Greene JP, Stafford E. Prevalence of Chlamydia trachomatis among active duty male soldiers reporting to a troop medical clinic for routine health care. South Med J May 2007; 100 (5): 478–81.
5. Franceschi S, Smith JS, van den Brule A et al. Cervical infection with Chlamydia trachomatis and Neisseria gonorrhoeae in women from ten areas in four continents. A cross-sectional study. Sex Transm Dis 2007; 34 (8): 563–9.
6. Yu MC, Li LH, Tang LH, Chen KT. Genital chlamydial infection among male attendees at a sexually transmitted disease clinic in urban Taiwan. Public Health 2007; 121 (7): 534–9.
7. Somani J, Bhullar VB, Workowski KA et al. Multiple drug-resistant Chlamydia trachomatis associated with clinical treatment failure. J Infect Dis 2000; 181 (4): 1421–7.
8. Workowski KA, Berman SM. Sexually transmitted diseases treatment guidelines, 2006. MMWR Recomm Rep 2006; 55 (RR-11): 1–94.
9. Radcliffe KW. Introduction. European STD guidelines. Int J STD AIDS 2001; 12 (Suppl. 3): 2–3.
10. WHO. Guidelines for the management of sexually transmitted infections. Geneva: World Health Organization; 2003.
11. Association for Genitourinary Medicine (AGUM) MSftSoVDM. 2002 national guideline on the management of non-gonococcal urethritis.: London: Association for Genitourinary Medicine (AGUM), Medical Society for the Study of Venereal Disease (MSSVD). 2002.
12. Lau CY, Qureshi AK. Azithromycin versus doxycycline for genital chlamydial infections: a meta-analysis of randomized clinical trials. Sex Transm Dis 2002; 29 (9): 497–502.
13. Geisler WM. Management of uncomplicated Chlamydia trachomatis infections in adolescents and adults: evidence reviewed for the 2006 Centers for Disease Control and Prevention sexually transmitted diseases treatment guidelines. Clin Infect Dis 2007; 44 (Suppl. 3): S77–83.
14. Higgins J, Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.0 [updated February 2008]. The Cochrane Collaboration, 2008. Chichester, UK: John Wiley & Sons, Ltd.; 2006.
15. Steingrimsson O, Olafsson JH, Thorarinsson H et al. Azithromycin in the treatment of sexually transmitted disease. J Antimicrob Chemother 1990; 25 (Suppl. A): 109–14.
16. Whatley JD, Thin RN, Mumtaz G, Ridgway GL. Azithromycin vs doxycycline in the treatment of non-gonococcal urethritis. Int J STD AIDS 1991; 2 (4): 248–51.
17. Martin DH, Mroczkowski TF, Dalu ZA et al. A controlled trial of a single dose of azithromycin for the treatment of chlamydial urethritis and cervicitis. The Azithromycin for Chlamydial Infections Study Group. N Engl J Med 1992; 327 (13): 921–5.
18. Nilsen A, Halsos A, Johansen A et al. A double blind study of single dose azithromycin and doxycycline in the treatment of chlamydial urethritis in males. Genitourin Med 1992; 68 (5): 325–7.
19. Lister PJ, Balechandran T, Ridgway GL, Robinson AJ. Comparison of azithromycin and doxycycline in the treatment of non-gonococcal urethritis in men. (Suppl. E) 1993; 31.
20. Lauharanta J, Saarinen K, Mustonen MT, Happonen HP. Single-dose oral azithromycin versus seven-day doxycycline in the treatment of non-gonococcal urethritis in males. J Antimicrob Chemother 1993; 31 (Suppl. E): 177–83.
21. Steingrimsson O, Olafsson JH, Thorarinsson H et al. Single dose azithromycin treatment of gonorrhea and infections caused by C. trachomatis and U. urealyticum in men. Sex Transm Dis 1994; 21 (1): 43–6.
22. Stamm WE, Hicks CB, Martin DH et al. Azithromycin for empirical treatment of the nongonococcal urethritis syndrome in men. A randomized double-blind study. Jama 1995; 274 (7): 545–9.
23. Jaspersen D. Drug Safety 2000; 22 (3): 237–49.
24. Bradshaw CS, Jensen JS, Tabrizi SN et al. Azithromycin failure in Mycoplasma genitalium urethritis. Emerg Infect Dis 2006; 12 (7): 1149–52.
25. Ross JD, Jensen JS. Mycoplasma genitalium as a sexually transmitted infection: implications for screening, testing, and treatment. Sex Transm Infect 2006; 82 (4): 269–71.
Авторы
К.Л.Локшин1, В.В.Рафальский2, С.В.Королев2
1. Урологическая клиника им. Р.М.Фронштейна, Московская медицинская академия им. И.М.Сеченова,
2. ГОУ ВПО Смоленская государственная медицинская академия Росздрава
1. Урологическая клиника им. Р.М.Фронштейна, Московская медицинская академия им. И.М.Сеченова,
2. ГОУ ВПО Смоленская государственная медицинская академия Росздрава
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.